What is the difference between BPC-157 and KPV?

Both are small peptides discussed for tissue and gut healing and both were part of the same July 2026 FDA advisory committee review of compounding candidates, but their evidence differs. BPC-157 has five small human studies behind it, fewer than 110 people total. KPV has none; this site's review found no published human trial for it, only preclinical and cell culture data on its anti-inflammatory activity.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of combining and comparing peptides. Stacks, head-to-head comparisons, and what happens when nobody has tested the combination.